Paper24100714
Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.
Taylor PN and 10 others. JAMA Intern Med, 2014. Cited by 239 papers, by iCite.
Cite this record
ConductScience Library. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. Papers, record 24100714. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24100714
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypothyroidism | Major topic |
| Thyrotropin | Major topic |
| Thyroxine | Major topic |
| Aged | |
| Cohort Studies | |
| Drug Therapy | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Odds Ratio | |
| Retrospective Studies | |
| Risk Assessment | |
| Treatment Outcome | |
| United Kingdom |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Medical Research Council | United Kingdom | PubMed |
Source PubMed
Comments and corrections5
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 24701880 | [Lower threshold of TSH for treatment of hypothyroidism: a benefit/risk balance remains uncertain]. | https://conductscience.org/library/papers/24701880 | PubMed |
| Comment in | 25058086 | Levothyroxine prescription: not as simple as it seems. | https://conductscience.org/library/papers/25058086 | PubMed |
| Comment in | 25730571 | Treatment of borderline elevated thyrotropin levels. | https://conductscience.org/library/papers/25730571 | PubMed |
| Comment in | 25730573 | Treatment of borderline elevated thyrotropin levels. | https://conductscience.org/library/papers/25730573 | PubMed |
| Comment in | 25730574 | Treatment of borderline elevated thyrotropin levels--reply. | https://conductscience.org/library/papers/25730574 | PubMed |
Cited by153
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 239 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985925 | Levothyroxine for subclinical hypothyroidism. | Cochrane Database Syst Rev | 2026 | https://conductscience.org/library/papers/42985925 | PubMed |
| 42611145 | Saraca asoca Alleviates PTU-Induced Hypothyroidism in Rats: Integrated LC-MS Profiling: In Vivo and Molecular Docking Analyses. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/42611145 | PubMed |
| 42249773 | Indications of over- and undertreatment of hypothyroidism in primary care: a scoping review and evidence mapping. | Scand J Prim Health Care | 2026 | https://conductscience.org/library/papers/42249773 | PubMed |
| 41961727 | Thyroid hormone therapy in a population cohort over two decades indicates persistent overtreatment. | Eur Thyroid J | 2026 | https://conductscience.org/library/papers/41961727 | PubMed |
| 41947333 | An Evaluation of Longitudinal Thyroid Hormone Levels Over the Years Before and After Patients Started on Levothyroxine. | Endocrinol Diabetes Metab | 2026 | https://conductscience.org/library/papers/41947333 | PubMed |
| 41941226 | Discontinuation of Levothyroxine in Adults Aged 60 Years or Older. | JAMA | 2026 | https://conductscience.org/library/papers/41941226 | PubMed |
| 41854012 | Real or Not Real? An Elevated TSH. | J Investig Med High Impact Case Rep | 2026 | https://conductscience.org/library/papers/41854012 | PubMed |
| 41685685 | Mechanisms and clinical prospects of mesenchymal stem cells and their derivatives in treating hypothyroidism-induced injuries: A focus on cardiovascular, skeletal muscle, and nervous systems. | Cell Transplant | 2026 | https://conductscience.org/library/papers/41685685 | PubMed |
| 41482002 | Approach to the Patient Considering Thyroid Hormone Deprescribing. | J Clin Endocrinol Metab | 2026 | https://conductscience.org/library/papers/41482002 | PubMed |
| 41400007 | Thyroid function and cognitive health: rethinking the relationship between "suboptimal" TSH/FT4 levels and cognitive decline. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/41400007 | PubMed |
| 40951414 | Knowledge gaps about the diagnosis and treatment of hypothyroidism: an international patient survey. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40951414 | PubMed |
| 40736623 | Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial. | Endocrine | 2025 | https://conductscience.org/library/papers/40736623 | PubMed |
| 40699541 | Italian guidelines for the management of adult individuals with primary hypothyroidism outside pregnancy. | J Endocrinol Invest | 2025 | https://conductscience.org/library/papers/40699541 | PubMed |
| 40584613 | Efficacy of Xiaoyao-san preparations in treating Hashimoto's thyroiditis: a meta-analysis and systematic review. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40584613 | PubMed |
| 40420166 | Importance of iodide sufficiency and normal thyroid function in fertility and during gestation. | Thyroid Res | 2025 | https://conductscience.org/library/papers/40420166 | PubMed |
| 40420021 | Psychological factors and obesity, not thyroid biomarkers, predict thyroid-dependent quality of life in treated hypothyroidism: a cross-sectional study. | BMC Endocr Disord | 2025 | https://conductscience.org/library/papers/40420021 | PubMed |
| 40376729 | Considerations in the Diagnosis and Management of Thyroid Dysfunction in Older Adults. | Thyroid | 2025 | https://conductscience.org/library/papers/40376729 | PubMed |
| 40179252 | Assessing the Cardiovascular Effects of Levothyroxine Use in an Ageing United Kingdom Population (ACEL-UK): Cohort Study. | J Clin Endocrinol Metab | 2025 | https://conductscience.org/library/papers/40179252 | PubMed |
| 39899246 | Thyroxine overuse and clinical indices guiding successful treatment withdrawal. | J Endocrinol Invest | 2025 | https://conductscience.org/library/papers/39899246 | PubMed |
| 39838463 | Sex differences in prevalence and clinical correlates of subclinical hypothyroidism in Chinese patients with first-episode untreated major depressive disorder. | BMC Psychiatry | 2025 | https://conductscience.org/library/papers/39838463 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24100714
GET https://conductscience.org/api/papers/v1/24100714/cited_by?page=2